 | Up a level |
Alomran, Nessrin, Blundell, Patricia, Alsolaiss, Jaffer, Crittenden, Edouard, Ainsworth, Stuart, Dawson, Charlotte A, Edge, Rebecca J, Hall, Steven R 
ORCID: 0000-0001-5314-4970, Harrison, Robert A, Wilkinson, Mark C et al (show 2 more authors)
(2022)
Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms.
TOXINS, 14 (7).
443-.
Clare, Rachel H, Dawson, Charlotte A, Westhorpe, Adam, Albulescu, Laura-Oana, Woodley, Christopher M, Mosallam, Nada, Chong, Daniel JW, Kool, Jeroen, Berry, Neil G ORCID: 0000-0003-1928-0738, O’Neill, Paul M et al (show 1 more authors)
(2024)
Snakebite drug discovery: high-throughput screening to identify novel snake venom metalloproteinase toxin inhibitors.
Frontiers in Pharmacology, 14.
1328950-.
Menzies, Stefanie K ORCID: 0000-0002-9273-9296, Dawson, Charlotte A, Crittenden, Edouard, Edge, Rebecca J, Hall, Steven R, Alsolaiss, Jaffer, Wilkinson, Mark C, Casewell, Nicholas R, Harrison, Robert A and Ainsworth, Stuart
(2022)
Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition.
SCIENTIFIC REPORTS, 12 (1).
11328-.
Albulescu, Laura-Oana, Xie, Chunfang, Ainsworth, Stuart, Alsolaiss, Jaffer, Crittenden, Edouard, Dawson, Charlotte A, Softley, Rowan, Bartlett, Keirah E ORCID: 0000-0003-3497-1385, Harrison, Robert A, Kool, Jeroen et al (show 1 more authors)
(2021)
A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite (vol 11, 6094, 2020).
NATURE COMMUNICATIONS, 12 (1).
4027-.